9th Trials Methodology Symposium (2025 – UCC)
Reamonn Madden, Innovation Capability Director, Novartis
Reamonn Madden is a member of the global clinical operations innovation group and leads the OneDCT working group within Novartis, leveraging over five years driving the execution of DCT elements in trials and over a decade in trial management and data management.
